Efficacy and safety of transcranial magnetic stimulation in the treatment of rare forms of muscular dystonia

Likhachev S.A.; Charnukha T.N.; Zabrodzets G.V.; Gleb O.V.

doi:https://doi.org/10.17116/jnevro20161162129-33

Likhachev S.A.

Republican Research and Clinical Center of Neurology and Neurosurgery

Charnukha T.N.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Zabrodzets G.V.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Gleb O.V.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Efficacy and safety of transcranial magnetic stimulation in the treatment of rare forms of muscular dystonia

Authors:

Likhachev S.A., Charnukha T.N., Zabrodzets G.V., Gleb O.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(2): 29‑33

DOI: 10.17116/jnevro20161162129-33

Read: 1269 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Likhachev SA, Charnukha TN, Zabrodzets GV, Gleb OV. Efficacy and safety of transcranial magnetic stimulation in the treatment of rare forms of muscular dystonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(2):29‑33. (In Russ.)
https://doi.org/10.17116/jnevro20161162129-33

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)

Использование инфографики авторами научных работ

Close metadata

OBJECTIVE

To evaluate the efficacy and safety of repetitive transcranial magnetic stimulation (rTMS) for the treatment of patients with dystonia.

MATERIAL AND METHODS

Authors treated 66 patients with segmental and generalized forms of dystonia, writer’s cramp and oromandibular dystonia. The degree of dystonia severity was assessed using the Burke—Fahn—Marsden scale.

RESULTS AND CONCLUSION

RTMS treatment of the motor cortex region decreased dystonic hyperkinesis severity. There was a significant decrease in scores on the Burke—Fahn—Marsden scale (p<0.05). This method was well-tolerated. No side-effects were observed, with the exception of one patient, who wished to discontinue treatment because of the twitching of facial muscles during rTMS. The results of the study allow to recommend wider adoption of this method in complex treatment and rehabilitation of patients with rare forms of dystonia.

Keywords:

dystonia

writer’s cramp

oromandibular dystonia

transcranial magnetic stimulation

Authors:

Likhachev S.A.

Republican Research and Clinical Center of Neurology and Neurosurgery

Charnukha T.N.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Zabrodzets G.V.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Gleb O.V.

Republican Research and Clinical Centre of Neurology and Neurosurgery

Close metadata

References:

Brin MF, Hallett M, Jankovic J. Scientific and therapeutic aspects of botulinum toxic. NY: Wilkins; 2002.
Albanese A, Asmus F, Bhatia KP et al. EFNS guidelines on diagnosis and treatment of primary dystonias. J Eur Neurol. 2011;18:5-18. https://doi.org/10.1111/j.1468-1331.2010.03042.x
Klein C, Ozelius L. Dystonia: clinical features, genetics, and treatment. Curr Opin Neurol. 2002;15:491-497. https://doi.org/10.1097/00019052-200208000-00014
Di Lazzaro V, Profice P, Pilato F et al. The effects of motor cortex rTMS on corticospinal descending activity. Clin Neurophysiol. 2010;121:464-473. https://doi.org/10.1016/j.clinph.2009.11.007
Tyvaert L, Houdayer E, Devanne H et al. The effect of repetitive transcranial magnetic stimulation on dystonia: a clinical and pathophysiological approach. Neurophysiol Clin. 2006;36:135-143. https://doi.org/10.1016/j.neucli.2006.08.007
Dressier D. Botulinum toxin therapy. Stuttgart: Thieme-Verlag; 2000;192.
Djebbari R, Montcel S, Sangla S et al. Factors predicting improvement in motor disability in writer’s cramp treated with botulinum toxin. J Neurol Neurosurg Psychiatry. 2004;75:1688-1691. https://doi.org/10.1136/jnnp.2003.032227
Chervyakov A.V. Transcranial magnetic stimulation as a method of neuromodulation in Parkinson's disease and dystonia. Bulletin of the National Society for the Study of Parkinson's Disease and Movement Disorders. 2011;2:15-21.
Rossi S, Hallett M, Rossini PM et al. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008-2039. https://doi.org/10.1016/j.clinph.2009.08.016
Lefaucheur JP, André-Obadia N, Antal A. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014;22:293-296. https://doi.org/10.1016/j.clinph.2014.05.021
Wassermann EM, Zimmermann T. Transcranial magnetic brain stimulation: therapeutic promises and scientific gaps. Pharmacol Ther. 2012;133:98-107. https://doi.org/10.1016/j.pharmthera.2011.09.003
Kamble N, Netravathi M, Pal PK. Therapeutic applications of repetitive transcranial magnetic stimulation (rTMS) in movement disorders: a review. Parkinsonism Relat Disord. 2014;20:695-707. https://doi.org/10.1016/j.parkreldis.2014.03.018
Siebner HR, Tormos JM, Ceballos-Baumann AO et al. Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer’s cramp. Neurology. 1999;52:529-537. https://doi.org/10.1212/wnl.52.3.529
Havrankova P, Jech R, Walker ND et al. Repetitive TMS of thesomatosensory cortex improves writer’s cramp and enhances cortical activity. Neuro Endocrinol Lett. 2010;31:73-86.
Stinear CM, Byblow WD. Impaired modulation of corticospinal excitability following subthresholdr TMS in focal hand dystonia. Hum Mov Sci. 2004;23:527-538. https://doi.org/10.1016/j.humov.2004.08.022
Kranz G, Shamim EA, Lin PT et al. Transcranial magnetic brain stimulation modulates blepharospasm: a randomized controlled study. Neurology. 2010;75:1465-1471. https://doi.org/10.1212/wnl.0b013e3181f8814d
Kimberley TJ, Borich MR, Arora S et al. Multiple sessions of low-frequency repetitive transcranial magnetic stimulation in focal hand dystonia: clinical and physiological effects. Restor Neurol Neurosci. 2013;31:533-542.